Articles citing this paper
Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV
Ioannis Hodges-Mameletzis A C , Shona Dalal A , Busisiwe Msimanga-Radebe B , Michelle Rodolph A and Rachel Baggaley A
+ Author Affiliations
- Author Affiliations
A World Health Organization, Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.
B World Health Organization, South Africa Country Office, 7th Floor Metro Park Building, 351 Francis Baard Street, Pretoria, 0002, South Africa.
C Corresponding author. Email: yanni.hodges@gmail.com
Sexual Health 15(6) 489-500 https://doi.org/10.1071/SH18125
Submitted: 29 June 2018 Accepted: 8 October 2018 Published: 29 November 2018
50 articles found in Crossref database.
Using the COM‐B model to characterize the barriers and facilitators of pre‐exposure prophylaxis (PrEP) uptake in men who have sex with men
Madhani Adam, Finlay Katherine A.
British Journal of Health Psychology. 2022 27(4). p.1330
Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines
Wang Zhicheng,
Grundy Quinn,
Parker Lisa, Bero Lisa
BMC Public Health. 2020 20(1).
Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection
Ong Jason J.,
Baggaley Rachel C.,
Wi Teodora E.,
Tucker Joseph D.,
Fu Hongyun,
Smith M. Kumi,
Rafael Sabrina,
Anglade Vanessa,
Falconer Jane,
Ofori-Asenso Richard,
Terris-Prestholt Fern,
Hodges-Mameletzis Ioannis, Mayaud Philippe
JAMA Network Open. 2019 2(12). p.e1917134
Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey
Belludi Ashwin,
McFall Allison M.,
Solomon Sunil Suhas,
Celentano David D.,
Mehta Shruti H.,
Srikrishnan A. K.,
Kumar M. Suresh,
Solomon Suniti,
Lucas Gregory M., Patel Rupa R.
PLOS ONE. 2021 16(2). p.e0247352
Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention
Karim Quarraisha Abdool,
Archary Derseree,
Barré-Sinoussi Françoise,
Broliden Kristina,
Cabrera Cecilia,
Chiodi Francesca,
Fidler Sarah J.,
Gengiah Tanuja N.,
Herrera Carolina,
Kharsany Ayesha B. M.,
Liebenberg Lenine J. P.,
Mahomed Sharana,
Menu Elisabeth,
Moog Christiane,
Scarlatti Gabriella,
Seddiki Nabila,
Sivro Aida, Cavarelli Mariangela
Frontiers in Immunology. 2022 13
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
Koppe Uwe,
Marcus Ulrich,
Albrecht Stefan,
Jansen Klaus,
Jessen Heiko,
Gunsenheimer-Bartmeyer Barbara, Bremer Viviane
BMC Public Health. 2021 21(1).
The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study
Velloza Jennifer,
Khoza Nomhle,
Scorgie Fiona,
Chitukuta Miria,
Mutero Prisca,
Mutiti Kudzai,
Mangxilana Nomvuyo,
Nobula Lumka,
Bulterys Michelle A,
Atujuna Millicent,
Hosek Sybil,
Heffron Renee,
Bekker Linda‐Gail,
Mgodi Nyaradzo,
Chirenje Mike,
Celum Connie, Delany‐Moretlwe Sinead
Journal of the International AIDS Society. 2020 23(3).
Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis
Nicol Melanie R,
Eneh Prosperity,
Nakalega Rita,
Kaiser Thomas,
Kabwigu Samuel,
Isingel Esther,
Beksinska Mags,
Sykes Craig,
Fowler Mary Glenn,
Brown Todd T,
Staley Christopher, Kiweewa Matovu Flavia
Clinical Infectious Diseases. 2020 70(8). p.1717
Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention
Stewart Jenell,
Bukusi Elizabeth,
Celum Connie,
Delany-Moretlwe Sinead, Baeten Jared M.
AIDS. 2020 34(5). p.651
Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and examples of successful health service models of PrEP implementation
Zablotska Iryna B.,
Baeten Jared M.,
Phanuphak Nittaya,
McCormack Sheena, Ong Jason
Sexual Health. 2018 15(6). p.481
Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
Bhavaraju Neeraja,
Shears Kathleen,
Schwartz Katie,
Mullick Saiqa,
Jeckonia Patriciah,
Murungu Joseph,
Persaud Udita,
Vij Ashley, Torjesen Kristine
Current HIV/AIDS Reports. 2021 18(6). p.508
PrEP monitoring and HIV incidence after PrEP initiation in France: 2016–18 nationwide cohort study
Tassi Marc-Florent,
Laurent Emeline,
Gras Guillaume,
Lot Florence,
Barin Francis,
de Gage Sophie Billioti,
Stefic Karl, Grammatico-Guillon Leslie
Journal of Antimicrobial Chemotherapy. 2021 76(11). p.3002
Immunoassay for HIV Drug Metabolites Tenofovir and Tenofovir Diphosphate
Sevenler Derin,
Bardon Ashley,
Fernandez Suarez Marta,
Marshall Lisa,
Toner Mehmet,
Drain Paul K., Sandlin Rebecca D.
ACS Infectious Diseases. 2020 6(7). p.1635
Pre-exposure prophylaxis (PrEP) and ‘risk’ in the news
Collins Luke C.
Journal of Risk Research. 2022 25(3). p.379
Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis
Nevendorff Laura,
Schroeder Sophia E.,
Pedrana Alisa,
Bourne Adam, Stoové Mark
Journal of the International AIDS Society. 2023 26(1).
Recent Advances and New Challenges in Cisgender Women’s Gynecologic and Obstetric Health in the Context of HIV
DEESE JENNIFER,
HEFFRON RENEE,
JASPAN HEATHER,
MASSON LINDI,
SMIT JENNIFER A., SIBEKO SENGEZIWE
Clinical Obstetrics & Gynecology. 2021 64(3). p.475
Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European Region – Results from a European survey study
Moseholm Ellen,
Gilleece Yvonne,
Collins Ben,
Kowalska Justyna D.,
Vasylyev Marta,
Pérez Elía María Jesús,
Cairns Gus, Aebi-Popp Karoline
Journal of Virus Eradication. 2021 7(1). p.100026
Brief Report: “What Is This PrEP?”—Sources and Accuracy of HIV Pre-Exposure Prophylaxis (PrEP) Awareness Among Adolescent Girls and Young Women Attending Family Planning and Maternal Child Health Clinics in Western Kenya
Dettinger Julia C.,
Pintye Jillian,
Dollah Annabell,
Awuor Mercy,
Abuna Felix,
Lagat Harrison,
Kohler Pamela,
John-Stewart Grace,
O'Malley Gabrielle,
Kinuthia John, Beima-Sofie Kristin
JAIDS Journal of Acquired Immune Deficiency Syndromes. 2021 88(4). p.356
PrEP Awareness, Use, Intention to Use, and Information Source Among Geosocial Networking Application Users in Mexico in 2018–2019
Blair Kevin J.,
Segura Eddy R.,
Garner Alex,
Lai Jianchao,
Ritterbusch Amy,
Leon-Giraldo Sebastian,
Guilamo-Ramos Vincent,
Lake Jordan E.,
Clark Jesse, Holloway Ian W.
AIDS and Behavior. 2021 25(9). p.2743
Impact along the HIV pre‐exposure prophylaxis “cascade of prevention” in western Kenya: a mathematical modelling study
Bershteyn Anna,
Sharma Monisha,
Akullian Adam N,
Peebles Kathryn,
Sarkar Supriya,
Braithwaite R Scott, Mudimu Edinah
Journal of the International AIDS Society. 2020 23(S3).
The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review
Vanhamel Jef,
Rotsaert Anke,
Reyniers Thijs,
Nöstlinger Christiana,
Laga Marie,
Van Landeghem Ella, Vuylsteke Bea
BMC Health Services Research. 2020 20(1).
Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus–Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings From the Expanded PrEP Implementation in Communities–New South Wales Prospective Implementation Study
Amin Janaki,
Vaccher Stefanie,
Templeton David J,
Bavinton Benjamin,
Jin Fengyi,
Zablotska Iryna,
Matthews Gail,
Ogilvie Erin,
Yeung Barbara,
Ooi Catriona,
Dharan Nila,
Baker David A,
Read Phillip,
Guy Rebecca, Grulich Andrew E
Clinical Infectious Diseases. 2022 75(9). p.1497
Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda
Lunkuse Jane Frances,
Kamacooko Onesmus,
Muturi-Kioi Vincent,
Chinyenze Kundai,
Kuteesa Monica O.,
Price Matt A., Mayanja Yunia
BMC Infectious Diseases. 2022 22(1).
Long-acting preexposure prophylaxis in low- and middle-income countries: key considerations for implementation
Kaewpoowat Quanhathai,
Chariyalertsak Suwat,
Phanuphak Nittaya, Ramautarsing Reshmie A.
Current Opinion in HIV and AIDS. 2022 17(3). p.135
Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions
Hodges-Mameletzis Ioannis,
Fonner Virginia A.,
Dalal Shona,
Mugo Nelly,
Msimanga-Radebe Busi, Baggaley Rachel
Drugs. 2019 79(12). p.1263
Conceptualizing safer sex in a new era: Risk perception and decision-making process among highly sexually active men who have sex with men
Dennermalm Nicklas,
Persson Kristina Ingemarsdotter,
Thomsen Sarah,
Forsberg Birger C.,
Alvesson Helle Mølsted, Pastor Bravo Maria del Mar
PLOS Global Public Health. 2022 2(5). p.e0000159
Women’s perspectives on relationship dynamics with their partners and their role in HIV acquisition, HIV disclosure, hormonal contraceptive uptake, and condom use
Chapola John C,
Hatfield-Timajchy Kendra,
Bula Agatha K,
Hurst Stacey,
Chinula Lameck,
Kourtis Athena P, Tang Jennifer H
African Journal of AIDS Research. 2021 20(1). p.61
Securing accelerated access to long‐acting injectable cabotegravir for HIV prevention in low‐ and middle‐income countries
Jenkins Sarah Y.,
Resar Danielle,
Panos Zachary,
Staple Alan,
Watkins Melynda,
Ripin David, Amole Carolyn
Journal of the International AIDS Society. 2023 26(S2).
Leveraging Resilience-supportive Strategies to Enhance Protective Factors in Young Sexual Minority Men: A Scoping Review of HIV Behavioral Interventions Implemented in High-income Countries
Meanley Steven,
Sexton Topper Patrina,
Listerud Louis,
Bonett Stephen K.,
Watson Dovie,
Choi Seul Ki,
Teixeira Da Silva Daniel,
Flores Dalmacio D.,
James Richard, Bauermeister José A.
The Journal of Sex Research. 2022 59(8). p.957
Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation
Calabrese Sarah K.
Current HIV/AIDS Reports. 2020 17(6). p.579
Improving WHO’s understanding of WHO guideline uptake and use in Member States: a scoping review
Saluja Kiran,
Reddy K. Srikanth,
Wang Qi,
Zhu Ying,
Li Yanfei,
Chu Xiajing,
Li Rui,
Hou Liangying,
Horsley Tanya,
Carden Fred,
Bartolomeos Kidist, Hatcher Roberts Janet
Health Research Policy and Systems. 2022 20(1).
Remaking HIV Prevention in the 21st Century (2021)
What makes an optimal delivery for PrEP against HIV: A qualitative study in MSM
Lau Janice Y. C.,
Wong Ngai-Sze,
Lee Krystal C. K.,
Kwan Tsz-Ho,
Lui Grace C. Y.,
Chan Denise P. C., Lee Shui-Shan
International Journal of STD & AIDS. 2022 33(4). p.322
COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise?
Mohamed Rahma,
Wanis Heba,
Zebachi Sonia,
El-Kotamy Menna-t-allah,
Esmat Gamal, Cordie Ahmed
Southern African Journal of HIV Medicine. 2020 21(1).
Utilization of HIV Pre-exposure Prophylaxis and Associated Factors Among Female Sex Workers in Bahir Dar City, North-West Ethiopia, Cross-sectional Study, 2022
Ademe Bezza,
Bogale Eyob, Anagaw Tadele
International Journal of General Medicine. 2023 Volume 16 p.6015
Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts
Shamu Simukai,
Shamu Patience,
Khupakonke Sikhulile,
Farirai Thato,
Chidarikire Thato,
Guloba Geoffrey, Nkhwashu Nkhensani
Global Health Action. 2021 14(1).
Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa
Moyo Enos,
Murewanhema Grant,
Musuka Godfrey, Dzinamarira Tafadzwa
Tropical Medicine and Infectious Disease. 2022 7(8). p.154
Remaking HIV Prevention in the 21st Century (2021)
Profilaxis Pre-Exposición en América Latina (Argentina, Brasil y México)
Maroni Adriel
Estudios Sociológicos de El Colegio de México. 2022 40(120). p.895
Readiness for Use of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in Malawi: Qualitative Focus Group and Interview Study
Mpunga Elizabeth,
Persaud Navindra,
Akolo Christopher,
Boyee Dorica,
Kamanga Gift,
Trapence Gift,
Chilongozi David,
Ruberintwari Melchiade, Masankha Banda Louis
JMIR Public Health and Surveillance. 2021 7(10). p.e26177
Eligibility for Pre-exposure Prophylaxis According to Different Guidelines in a Cohort of HIV-Negative Men Who Have Sex with Men in Lisbon, Portugal
Meireles Paula,
Plankey Michael,
Rocha Miguel,
Rojas Jesus,
Brito João, Barros Henrique
Sexuality Research and Social Policy. 2020 17(4). p.688
Estimating the budget impact of adopting tenofovir/emtricitabine for pre-exposure prophylaxis of HIV in the public health sector in Namibia (2021 – 2023)
Moyo Enos,
Barham Leela,
Mhango Malizgani,
Musuka Godfrey, Dzinamarira Tafadzwa
Journal of Infection and Public Health. 2022 15(10). p.1147
A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication
Cattaneo Dario,
Gervasoni Cristina,
Vinti Pietro,
Baldelli Sara,
Fusi Marta,
Zagato Donatello,
De Bona Anna,
Suardi Elisa,
Bossolasco Simona,
Ancona Giuseppe,
Rossotti Roberto, Cernuschi Massimo
Therapeutic Drug Monitoring. 2020 42(4). p.643
Factors Associated with PrEP Persistence and Loss of Follow-Up: A 5-Year Historic Cohort
Le Roux Clément,
Tassi Marc-Florent,
Faussat Cathie,
Aumond Catherine,
Gras Guillaume,
Stefic Karl, Grammatico-Guillon Leslie
Archives of Sexual Behavior. 2024 53(7). p.2445
“Yes, I’m interested in taking PrEP!”: PrEP interest among women respondents to the European community-based survey “Flash! PrEP in Europe”
Delabre Rosemary M.,
Bernier Adeline,
Sánchez Flor,
Vilotitch Antoine,
Chanos Sophocles,
Cosmaro Maria Luisa,
Langanke Harriet,
Mey Coline,
James Cary,
Duken Sascha B.,
Schlegel Vincent,
Stranz Richard,
Jonas Kai J.,
Spire Bruno,
Rojas Castro Daniela, Smith Dawn K.
PLOS ONE. 2021 16(2). p.e0246037
HIV prevention and treatment in Southern Europe in the aftermath of bailout programmes
Augusto Gonçalo F,
Hodges-Mameletzis Ioannis,
Karanikolos Marina,
Abrantes Alexandre, Martins Maria R O
European Journal of Public Health. 2020 30(5). p.967
Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen
Mujugira Andrew,
Baeten Jared M.,
Hodges-Mameletzis Ioannis, Haberer Jessica E.
Drugs. 2020 80(18). p.1881
A rapid review of pre-exposure prophylaxis for HIV in the Asia–Pacific region: recommendations for scale up and future directions
Haldar Partha,
Reza-Paul Sushena,
Daniel Roy Arokiam,
Lazarus Lisa,
Rewari Bharat Bhushan,
Lorway Robert, Steen R.
Sexual Health. 2021 18(1). p.31
Reddit on PrEP: Posts About Pre-exposure Prophylaxis for HIV from Reddit Users, 2014–2019
Loosier Penny S.,
Renfro Kaytlin,
Carry Monique,
Williams Samantha P.,
Hogben Matthew, Aral Sevgi
AIDS and Behavior. 2022 26(4). p.1084
A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial
Kawichai Surinda,
Songtaweesin Wipaporn Natalie,
Wongharn Prissana,
Phanuphak Nittaya,
Cressey Tim R,
Moonwong Juthamanee,
Vasinonta Anuchit,
Saisaengjan Chutima,
Chinbunchorn Tanat, Puthanakit Thanyawee
JMIR mHealth and uHealth. 2022 10(4). p.e25561
